Valuation
- Market cap
- 5,939,000
- Revenue TTM
- $450,000
- Net income TTM
- $-660,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -146.67%
- Debt to equity
- 0.04
Trading
- Volume
- 74,891,297
- Avg volume
- 1,592,902
- Day's range
- $0.39 – $1.09
- Shares out
- 6,582,000
- Stochastic %K
- 73%
- Beta
- 5.40
- Analysts
- —
- Price target
- —
Company profile
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for tre...
Show more
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is headquartered in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 86 10 8481 7665
- Website
- https://www.ftzy.com.cn
- Address
- NET Building, Room 306 Hong Jun Ying South Road Chaoyang District, Beijing, China
Latest news
No headlines yet.
